Skip to content
10-Q

Quarterly Report

Cyteir Therapeutics, Inc.

0000950170-23-039033

← back to feed
Filed
Aug 7, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Aug 4, 2023 36M sh
Shares Diluted Q2 2023 · Jun 30, 2023 35.74M sh
Shares Diluted Q2 2023 · Jun 30, 2023 35.65M sh
Shares Diluted Q2 2023 · Jun 30, 2022 35.28M sh
Shares Diluted Q2 2023 · Jun 30, 2022 35.26M sh
Operating Cash Flow Q2 2023 · Jun 30, 2023 −$14.32M
Operating Cash Flow Q2 2023 · Jun 30, 2022 −$23.05M
Cash And Equivalents Q2 2023 · Jun 30, 2023 $133.64M
Cash And Equivalents Q2 2023 · Dec 31, 2022 $147.12M
Cash And Equivalents Q2 2023 · Jun 30, 2022 $166.4M
Stockholders Equity Q2 2023 · Jun 30, 2023 $127.79M
Stockholders Equity Q2 2023 · Mar 31, 2023 $134.98M
Stockholders Equity Q2 2023 · Dec 31, 2022 $146.29M
Stockholders Equity Q2 2023 · Jun 30, 2022 $163.78M
Stockholders Equity Q2 2023 · Mar 31, 2022 $174.5M
Stockholders Equity Q2 2023 · Dec 31, 2021 $187.29M
Current Liabilities Q2 2023 · Jun 30, 2023 $6.58M
Current Liabilities Q2 2023 · Dec 31, 2022 $5.32M
Total Liabilities Q2 2023 · Jun 30, 2023 $6.6M
Total Liabilities Q2 2023 · Dec 31, 2022 $6.95M
Current Assets Q2 2023 · Jun 30, 2023 $133.91M
Current Assets Q2 2023 · Dec 31, 2022 $149.21M
Total Assets Q2 2023 · Jun 30, 2023 $134.39M
Total Assets Q2 2023 · Dec 31, 2022 $153.23M
Eps Diluted Q2 2023 · Jun 30, 2023 −$0.24
Eps Diluted Q2 2023 · Jun 30, 2023 −$0.59
Eps Diluted Q2 2023 · Jun 30, 2022 −$0.34
Eps Diluted Q2 2023 · Jun 30, 2022 −$0.74
Eps Basic Q2 2023 · Jun 30, 2023 −$0.24
Eps Basic Q2 2023 · Jun 30, 2023 −$0.59
Eps Basic Q2 2023 · Jun 30, 2022 −$0.34
Eps Basic Q2 2023 · Jun 30, 2022 −$0.74
Sga Expense Q2 2023 · Jun 30, 2023 $4.2M
Sga Expense Q2 2023 · Jun 30, 2023 $8.31M
Sga Expense Q2 2023 · Jun 30, 2022 $3.43M
Sga Expense Q2 2023 · Jun 30, 2022 $7.48M
Rd Expense Q2 2023 · Jun 30, 2023 $5.4M
Rd Expense Q2 2023 · Jun 30, 2023 $14.72M
Rd Expense Q2 2023 · Jun 30, 2022 $8.79M
Rd Expense Q2 2023 · Jun 30, 2022 $18.88M
Net Income Q2 2023 · Jun 30, 2023 −$8.4M
Net Income Q2 2023 · Jun 30, 2023 −$20.89M
Net Income Q2 2023 · Mar 31, 2023 −$12.49M
Net Income Q2 2023 · Jun 30, 2022 −$12.12M
Net Income Q2 2023 · Jun 30, 2022 −$26.22M
Net Income Q2 2023 · Mar 31, 2022 −$14.1M
Operating Income Q2 2023 · Jun 30, 2023 −$9.61M
Operating Income Q2 2023 · Jun 30, 2023 −$23.03M
Operating Income Q2 2023 · Jun 30, 2022 −$12.23M
Operating Income Q2 2023 · Jun 30, 2022 −$26.36M
Capex Q2 2023 · Jun 30, 2022 $302K